Overview

Apremilast for Atopic Dermatitis - A Pilot Study in Adults

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain preliminary data regarding the safety and tolerability of apremilast in AD to support the design of larger controlled studies.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Celgene Corporation
Treatments:
Apremilast
Thalidomide